Quest Diagnostics Aims to Bolster its Genetic Testing Platform with Celera Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 4 (Table of Contents)
Published: 5 Apr-2011
DOI: 10.3833/pdr.v2011.i4.1453 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Quest Diagnostics has agreed to acquire Celera in a merger deal valued at US$344 M, net of US$327 M in acquired cash and short-term investments...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS